| scholarly article | Q13442814 |
| P2093 | author name string | Gerard K Jeong | |
| Harvinder S Sandhu | |||
| James Farmer | |||
| P2860 | cites work | OP-1 cDNA encodes an osteogenic protein in the TGF-beta family | Q24338365 |
| Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation | Q24616097 | ||
| Bone: formation by autoinduction | Q28251545 | ||
| Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily | Q28292733 | ||
| A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions | Q30423943 | ||
| Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety | Q77924929 | ||
| Immunolocalization of bone morphogenetic protein and its receptors in degeneration of intervertebral disc | Q78051359 | ||
| Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages | Q78412809 | ||
| Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells | Q80601733 | ||
| A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions | Q30423956 | ||
| Bone graft and bone graft substitutes: a review of current technology and applications | Q33563643 | ||
| Bioactive factors for bone tissue engineering | Q33765003 | ||
| Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation | Q34452149 | ||
| Morbidity at bone graft donor sites | Q34549541 | ||
| Bone-grafting and bone-graft substitutes. | Q34557248 | ||
| Pseudarthrosis of the spine | Q35372073 | ||
| A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis | Q35943780 | ||
| The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2 | Q41718333 | ||
| Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate | Q42604254 | ||
| Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model | Q42635764 | ||
| Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion | Q43688848 | ||
| The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro | Q44552343 | ||
| Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction | Q45226134 | ||
| Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion | Q46169377 | ||
| Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells | Q46290804 | ||
| Intertransverse process lumbar arthrodesis with allogeneic fresh-frozen bone graft | Q46723864 | ||
| Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction | Q47412645 | ||
| A Cost Analysis of Bone Morphogenetic Protein Versus Autogenous Iliac Crest Bone Graft in Single-Level Anterior Lumbar Fusion | Q47425058 | ||
| Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies | Q48360114 | ||
| 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion | Q48370655 | ||
| Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep | Q50128375 | ||
| Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms. | Q52190075 | ||
| Osteogenic protein-1 is required for mammalian eye development. | Q52202985 | ||
| Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. | Q53666263 | ||
| Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. | Q53960798 | ||
| Donor site pain from the ilium. A complication of lumbar spine fusion. | Q54347528 | ||
| Response of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits | Q68136809 | ||
| Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1 | Q68186574 | ||
| Experimental spinal fusion with decalcified bone matrix and deep-frozen allogeneic bone in rabbits | Q70224622 | ||
| Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion | Q71729482 | ||
| Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development | Q71746376 | ||
| Experimental spinal fusion with recombinant human bone morphogenetic protein-2 | Q72062770 | ||
| A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients | Q72417723 | ||
| In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions | Q72840259 | ||
| Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion | Q73185913 | ||
| OP-1 enhances dendritic growth from cerebral cortical neurons in vitro | Q73343132 | ||
| Osteogenic protein-1 mRNA in the uterine endometrium | Q73381746 | ||
| Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements | Q73455918 | ||
| The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report | Q73511686 | ||
| Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts | Q74172123 | ||
| Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage | Q74551626 | ||
| Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device | Q74668123 | ||
| The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model | Q77345165 | ||
| Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate | Q77627852 | ||
| P433 | issue | 1 | |
| P921 | main subject | neurosurgery | Q188449 |
| P304 | page(s) | 110-117 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | HSS Journal | Q5636001 |
| P1476 | title | Bone morphogenic proteins: applications in spinal surgery | |
| P478 | volume | 1 |
| Q52647396 | Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain. | cites work | P2860 |
Search more.